Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KT Medical Service PCLBKK:KTMS +9.09%72 3-Year EBITDA Growth Rate is 16.60% as of Jun. 2026, which is 13% above its 10-year median of 14.65. GuruFocus rates BKK:KTMS with a GF Score™ of 72/100 and a GF Value™ of ฿2.26 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 526 Healthcare Providers & Services companies, KT Medical Service PCL ranks better than 61.22% on this metric.
During the past 12 months, KT Medical Service PCL's average EBITDA Per Share Growth Rate was 15.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 16.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of KT Medical Service PCL was 16.60% per year. The lowest was 12.70% per year. And the median was 14.65% per year.
KT Medical Service PCL (BKK:KTMS) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
KT Medical Service PCL 3-Year EBITDA Growth Rate Related Terms
BKK:KTMS vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, KT Medical Service PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KT Medical Service PCL 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KT Medical Service PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where KT Medical Service PCL's 3-Year EBITDA Growth Rate falls into.
KT Medical Service PCL 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 16.60% mean?
KT Medical Service PCL (BKK:KTMS) has a 3-Year EBITDA Growth Rate of 16.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for KT Medical Service PCL and its competitors. This is 13% above median its historical median of 14.65. Over the past decade, KT Medical Service PCL's 3-Year EBITDA Growth Rate has ranged from 12.70 to 16.60. According to the industry distribution chart, KT Medical Service PCL ranks #204 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 38.8%.
Is KT Medical Service PCL's 3-Year EBITDA Growth Rate too high?
KT Medical Service PCL's current 3-Year EBITDA Growth Rate of 16.60% is 13% above median its 10-year median of 14.65. Over the past 10 years, this metric has ranged from a low of 12.70 to a high of 16.60. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. KT Medical Service PCL's value of 16.60% is 65.2% above this industry median. Based on the distribution chart, KT Medical Service PCL ranks #204 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, KT Medical Service PCL has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does KT Medical Service PCL's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, KT Medical Service PCL ranks #204 out of 526 companies for 3-Year EBITDA Growth Rate. This puts KT Medical Service PCL in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. KT Medical Service PCL's value of 16.60% is 65.2% above this benchmark. Historically, KT Medical Service PCL's own 3-Year EBITDA Growth Rate has ranged from 12.70 to 16.60 over the past decade. While the company's 10-year median is 14.65 vs. the industry median of 10.05, KT Medical Service PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KT Medical Service PCL's current 3-Year EBITDA Growth Rate of 16.60% is 65.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for KT Medical Service PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KT Medical Service PCL's current 3-Year EBITDA Growth Rate is 16.60%, which is 13% above median its own 10-year median of 14.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KT Medical Service PCL stock overvalued right now?
Based on GuruFocus' analysis, KT Medical Service PCL (BKK:KTMS) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿2.26, compared to a current price of ฿1.44 — trading 36.3% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 16.60%, which is 13% above median its 10-year median of 14.65 and 65.2% above the Healthcare Providers & Services industry median of 10.05. KT Medical Service PCL's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For KT Medical Service PCL (BKK:KTMS), the current 3-Year EBITDA Growth Rate is 16.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KT Medical Service PCL (BKK:KTMS) Overvalued in 2026?
Based on GuruFocus' analysis, KT Medical Service PCL stock appears to be undervalued.
The current stock price of ฿1.44 is trading 36.3% below its estimated GF Value™ of ฿2.26.
GuruFocus considers KT Medical Service PCL to be Significantly Undervalued.
Key valuation signals for BKK:KTMS:
3-Year EBITDA Growth Rate: 16.60% (13% above median its 10-year median of 14.65)
GF Value™: ฿2.26 vs. price of ฿1.44 (36.3% below fair value)
Industry Position: 65.2% above the Healthcare Providers & Services median (#204 of 526)
No single metric tells the full story. See the BKK:KTMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KT Medical Service PCL operates in Thailand and engages in hemodialysis center, design, assembly and installation of pure water treatment system and service preventive maintenance of pure water treatment system for commercial and residential sectors, the industrial and original equipment manufacturing of water system sector and medical service sector. The company's segments include Service of hemodialysis, Service of design and installation of pure water treatment system and the service preventive maintenance of pure water treatment system for medical service, and Services of design and installation of pneumatic tube system of equipment for medical service. It derives majority of the revenue from Service of hemodialysis segment.
72GF Score
Get the complete analysis for BKK:KTMS
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KTMS has been successfully added to your 
